Results 261 to 270 of about 1,554,548 (330)
Enhancing radiosensitization, modulating the tumor immune microenvironment, and ensuring complete resection are crucial for colorectal cancer (CRC) treatment. This study presents a multifunctional NIR‐II fluorescent nanoprobe, RVLu@ICG, which enhances radiosensitization, remodels the tumor immune microenvironment, and enables precise image‐guided ...
Yongying Dang+10 more
wiley +1 more source
Molybdenum (Mo), with its unique strength, uniform corrosion, and radiopacity, enables innovative biodegradable implants for transformative stroke therapy. Abstract Neurovascular implants for stroke intervention face a critical dilemma: permanent devices (e.g., nitinol stents, platinum coils) often trigger chronic inflammation and recurrence, whereas ...
Yunong Shen+11 more
wiley +1 more source
Producing Photoactivated Room Temperature Phosphorescent Glass from Bamboo
Room‐temperature phosphorescent (RTP) glass (B‐glass) is developed from natural bamboo. The as‐prepared B‐glass demonstrates unique photoactivated RTP characteristics and superior mechanical properties, which can serve as a reprogrammable platform for 3D luminescent architectures and multilevel optical data storage.
Shaodi Zhang+9 more
wiley +1 more source
A lignin‐derived ionogel is developed through a straightforward, one‐step solvent‐free process. By leveraging arginine‐grafted lignin‐terminated polythioctic acid and incorporating imine and hydroxyl groups into the supramolecular framework. Its dynamic disulfide/hydrogen‐bond dual networks enable balanced stretchability‐reversibility while delivering ...
Zhimin Kou+9 more
wiley +1 more source
Electrostatically intercalated MgAl‐layered double hydroxide (LDH) nanosheets act as non‐redox spacers to prevent rGO restacking via a self‐assembly process. Such layer‐by‐layer structure provides accessible nano‐channels for rapid ion transport, exhibiting high capacitance (410 F g−1) with robust retention and cycling stability. This strategy provides
Xiaojun Ren+10 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Research Journal of Pharmacy and Technology, 2018
Premarket approval application is not essential but 510(k) must submit to FDA to market medical device in the U.S for human use. To conclude or to determine the device is substantially equivalent to the device which is already marketed. After getting a 510(k) clearance immediately device can be marketed by submitter. In such case where already marketed
Santhosh S, R. Kamaraj
openaire +3 more sources
Premarket approval application is not essential but 510(k) must submit to FDA to market medical device in the U.S for human use. To conclude or to determine the device is substantially equivalent to the device which is already marketed. After getting a 510(k) clearance immediately device can be marketed by submitter. In such case where already marketed
Santhosh S, R. Kamaraj
openaire +3 more sources
Modernizing the FDA’s 510(k) Pathway
New England Journal of Medicine, 2019Modernizing the FDA’s 510(k) Pathway More than 90% of FDA-reviewed devices enter the market by means of the 510(k) pathway. In September 2019, the FDA finalized reforms to the pathway.
Vinay K. Rathi, Joseph S. Ross
openaire +3 more sources
Analytical Chemistry, 2023
Surgical resection constitutes the first choice of treatment for colorectal cancer (CRC). Despite advancements in intraoperative navigation, there remains a considerable lack of effective targeting probes for the imaging-guided surgical navigation of CRC
Ping Luo+6 more
semanticscholar +1 more source
Surgical resection constitutes the first choice of treatment for colorectal cancer (CRC). Despite advancements in intraoperative navigation, there remains a considerable lack of effective targeting probes for the imaging-guided surgical navigation of CRC
Ping Luo+6 more
semanticscholar +1 more source
Analysis of Complications in Sacroiliac Joint Fusions Using FDA 510(k) Cleared Devices
Clinical Spine Surgery, 2021Study Design: This was a level III—retrospective cohort study. Objective: The objective of this study was to present an unbiased report of the current rate of severe complications for Federal Drug Administration (FDA) 510(k) cleared sacroiliac joint (SIJ)
Michael D. Rahl+2 more
semanticscholar +1 more source